Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALR
2926
DELISTED
AlerisLife Inc
ALR
| $592K | ﹤0.01% |
128,524
+6,860
| +6% | +$39.3K |
|
|
ORKA
2927
Oruka Therapeutics
ORKA
$5.31B
| $589K | ﹤0.01% |
6,707
+2,533
| +61% | +$227K |
|
2928
Stagwell
STGW
$2B
| $586K | ﹤0.01% |
232,400
+166,400
| +252% | +$428K |
|
|
SMIT
2929
DELISTED
Schmitt Industries Inc
SMIT
| $586K | ﹤0.01% |
260,348
-1,060
| -0.4% | -$2.4K |
|
|
DLA
2930
DELISTED
Delta Apparel Inc.
DLA
| $584K | ﹤0.01% |
25,200
-4,100
| -14% | -$93.2K |
|
2931
Retractable Technologies
RVP
$20.1M
| $583K | ﹤0.01% |
805,038
+77,111
| +11% | +$53.4K |
|
2932
VSE Corp
VSEC
$5.19B
| $580K | ﹤0.01% |
20,200
-16,600
| -45% | -$476K |
|
2933
Optical Cable Corp
OCC
$113M
| $578K | ﹤0.01% |
140,203
-3,101
| -2% | -$13.9K |
|
|
EVOL
2934
DELISTED
Evolving Systems, Inc.
EVOL
| $578K | ﹤0.01% |
731,955
+10,043
| +1% | +$10.2K |
|
2935
iShares Core S&P US Growth ETF
IUSG
$30.4B
| $577K | ﹤0.01% |
+9,200
| New | +$566K |
|
2936
Oramed Pharmaceuticals
ORMP
$162M
| $568K | ﹤0.01% |
158,098
+53,043
| +50% | +$187K |
|
|
LITB
2937
LightInTheBox
LITB
$50.6M
| $567K | ﹤0.01% |
63,874
-2,784
| -4% | -$25.1K |
|
2938
Target Hospitality
TH
$1.43B
| $567K | ﹤0.01% |
+62,300
| New | +$631K |
|
|
FSFG
2939
DELISTED
First Savings Financial Group
FSFG
| $564K | ﹤0.01% |
28,200
+16,500
| +141% | +$314K |
|
2940
Vanguard S&P 500 Growth ETF
VOOG
$24.7B
| $564K | ﹤0.01% |
+21,000
| New | +$553K |
|
2941
ClearOne Inc
CLRO
$12M
| $563K | ﹤0.01% |
16,825
+640
| +4% | +$20.8K |
|
|
PBT
2942
Permian Basin Royalty Trust
PBT
$1.36B
| $563K | ﹤0.01% |
92,401
+67,300
| +268% | +$433K |
|
|
FM
2943
DELISTED
iShares Frontier and Select EM ETF
FM
| $563K | ﹤0.01% |
+19,000
| New | +$548K |
|
|
FTSI
2944
DELISTED
FTS International, Inc. Common Stock
FTSI
| $562K | ﹤0.01% |
5,035
-2,560
| -34% | -$423K |
|
|
ICD
2945
DELISTED
Independence Contract Drilling, Inc.
ICD
| $561K | ﹤0.01% |
17,755
+5,320
| +43% | +$260K |
|
2946
Electromed
ELMD
$333M
| $558K | ﹤0.01% |
102,340
+14,100
| +16% | +$77.2K |
|
2947
Veru
VERU
$35.5M
| $558K | ﹤0.01% |
26,216
+16,955
| +183% | +$287K |
|
2948
Moog Inc Class B
MOG.B
$12.7B
| $557K | ﹤0.01% |
6,000
+400
| +7% | +$36K |
|
2949
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.71B
| $553K | ﹤0.01% |
+8,300
| New | +$542K |
|
2950
Gaia
GAIA
$46.6M
| $552K | ﹤0.01% |
72,800
-34,300
| -32% | -$288K |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.